← FDA Drug Approvals (Drugs@FDA)

VASOPRESSIN IN DEXTROSE 5%

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2024-02-09

Drug application

FDA Application #

ANDA216963

Application type

Abbreviated New Drug Application (Generic)

Brand name

VASOPRESSIN IN DEXTROSE 5%

Generic name

VASOPRESSIN

Active ingredients

VASOPRESSIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Sagent Pharmaceuticals

First approval

2024-02-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown